- Home
- CDNA vs ADSE Comparison
CDNA vs ADSE Comparison
Compare CDNA & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- ADSE
- Stock Information
- Founded
- CDNA 1998
- ADSE 1980
- Country
- CDNA United States
- ADSE Ireland
- Employees
- CDNA N/A
- ADSE N/A
- Industry
- CDNA Medical Specialities
- ADSE Industrial Specialties
- Sector
- CDNA Health Care
- ADSE Consumer Discretionary
- Exchange
- CDNA Nasdaq
- ADSE Nasdaq
- Market Cap
- CDNA 844.7M
- ADSE 777.7M
- IPO Year
- CDNA 2014
- ADSE N/A
- Fundamental
- Price
- CDNA $16.99
- ADSE $12.50
- Analyst Decision
- CDNA Buy
- ADSE
- Analyst Count
- CDNA 6
- ADSE 0
- Target Price
- CDNA $30.33
- ADSE N/A
- AVG Volume (30 Days)
- CDNA 1.4M
- ADSE 70.0K
- Earning Date
- CDNA 04-30-2025
- ADSE 05-12-2025
- Dividend Yield
- CDNA N/A
- ADSE N/A
- EPS Growth
- CDNA N/A
- ADSE N/A
- EPS
- CDNA 1.07
- ADSE N/A
- Revenue
- CDNA $346,421,000.00
- ADSE $113,896,884.00
- Revenue This Year
- CDNA $13.38
- ADSE $219.58
- Revenue Next Year
- CDNA $15.33
- ADSE N/A
- P/E Ratio
- CDNA $15.81
- ADSE N/A
- Revenue Growth
- CDNA 25.92
- ADSE 2.45
- 52 Week Low
- CDNA $12.90
- ADSE $10.17
- 52 Week High
- CDNA $34.84
- ADSE $16.35
- Technical
- Relative Strength Index (RSI)
- CDNA 49.78
- ADSE 45.53
- Support Level
- CDNA $16.57
- ADSE $11.07
- Resistance Level
- CDNA $18.02
- ADSE $13.36
- Average True Range (ATR)
- CDNA 0.77
- ADSE 1.04
- MACD
- CDNA 0.14
- ADSE 0.05
- Stochastic Oscillator
- CDNA 59.45
- ADSE 57.66
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.